It is our purpose to continue the study of the molecular biology of the human dependovirus, adeno-associated virus (AAV) 2. In the past several years, we have come to believe the AAV is not defective but rather is a virus which preferentially in healthy cells inhibits its own gene expression and DNA replication to enhance the ability of the viral DNA to integrate into the cellular genome. When the cell is infected by adeno- or herpes virus or exposed to toxic treatment, the intracellular milieu is changed to one that is permissive for production of AAV virions. This proposal contains an experimental program designed to investigate the following areas: 1. All of the trans-acting regulatory functions of AAV are encoded in the rep gene. We shall study a) the cis active negative regulation of rep during productive infection; b) negative regulation of AAV promoters by rep under nonpermissive conditions; c) regulation by rep of gene expression at the translational level; d) the mechanism whereby the SV40 regulatory region is controlled by being put into the AAV genome. 2. We shall study the mechanism of replication of cloned AAV genomes with partially deleted terminal repeats and try to establish an in vitro assay for DNA replication. 3. We have preliminary data that suggest that AAV integration in human cells is into a specific sequence on chromosome 21. We wish to confirm this and determine and map the sequence on chromosome 21.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI022251-12
Application #
2061768
Study Section
Special Emphasis Panel (NSS)
Project Start
1984-08-02
Project End
1999-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Berns, K I; Meneses, P; Duvoisin, R et al. (2001) Use of recombinant angiostatin to prevent retinal neovascularization. Trans Am Clin Climatol Assoc 112:68-75; discussion 75-6
Meneses, P I; Hajjar, K A; Berns, K I et al. (2001) Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model. Gene Ther 8:646-8
Dyall, J; Szabo, P; Berns, K I (1999) Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system. Proc Natl Acad Sci U S A 96:12849-54
Linden, R M; Ward, P; Giraud, C et al. (1996) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A 93:11288-94
Linden, R M; Winocour, E; Berns, K I (1996) The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A 93:7966-72
Berns, K I; Linden, R M (1995) The cryptic life style of adeno-associated virus. Bioessays 17:237-45
Leonard, C J; Berns, K I (1994) Cloning, expression, and partial purification of Rep78: an adeno-associated virus replication protein. Virology 200:566-73
Leonard, C J; Berns, K I (1994) Adeno-associated virus type 2: a latent life cycle. Prog Nucleic Acid Res Mol Biol 48:29-52
Giraud, C; Winocour, E; Berns, K I (1994) Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A 91:10039-43
Hong, G; Ward, P; Berns, K I (1992) In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A 89:4673-7

Showing the most recent 10 out of 23 publications